N

Active Director Designated Partner DIN 10037750
DIN 10037750 First appointment Jan 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nagajothi

Data last updated:

Nagajothi is a Designated Partner at Accvus Pharmaceuticals Llp (since 2023). The company operates in Paper.

DIN 10037750
Primary Designation Designated Partner
Industry Paper
First Appointment 09 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Jan 20232023Active

Board colleagues of Nagajothi

NameDINCompanyDesignation
Gandhi Maruthupandi10037749Accvus Pharmaceuticals LlpDesignated Partner
Ganesh Raj09258773Accvus Pharmaceuticals LlpDesignated Partner
Suresh Kumar10664895Accvus Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Accvus Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Nagajothi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagajothi

Nagajothi currently holds 1 directorship: Accvus Pharmaceuticals Llp (Designated Partner, since 09 Jan 2023).

Nagajothi was first appointed on 09 Jan 2023 as Designated Partner at Accvus Pharmaceuticals Llp.

The current boards of Nagajothi's companies include Gandhi Maruthupandi (Accvus Pharmaceuticals Llp), Ganesh Raj (Accvus Pharmaceuticals Llp), Suresh Kumar (Accvus Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available